XML 202 R145.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated shareholders’ equity - Summary of Stock Options Outstanding at Each Balance Sheet Date (Details) - Total stock option plans
€ / shares in Units, € in Millions
12 Months Ended
Dec. 31, 2024
EUR (€)
shares
€ / shares
Dec. 31, 2023
EUR (€)
shares
€ / shares
Dec. 31, 2022
EUR (€)
shares
€ / shares
Dec. 31, 2021
EUR (€)
shares
€ / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Number of options, beginning balance (in shares) | shares 1,333,013 1,837,969 2,337,968  
Number of options, options exercisable (in shares) | shares 934,444 1,333,013 1,624,569 1,949,184
Number of options, options exercised (in shares) | shares (398,569) (504,956) (490,373)  
Number of options, options cancelled (in shares) | shares     (9,626) [1]  
Number of options, ending balance (in shares) | shares 934,444 1,333,013 1,837,969 2,337,968
Average exercise price per share, beginning balance (in euros per share) | € / shares € 80.53 € 78.64 € 77.13  
Average exercise price per share, options exercisable (in euros per share) | € / shares 80.16 80.53 78.89 € 78.15
Average exercise price per share, options exercised (in euros per share) | € / shares 81.38 73.65 71.39  
Average exercise price per share, options cancelled (in euros per share) | € / shares     80.56 [1]  
Average exercise price per share, ending balance (in euros per share) | € / shares € 80.16 € 80.53 € 78.64 € 77.13
Total, beginning balance | € € 107 € 144 € 180  
Total, options exercisable | € 75 107 128 € 152
Total, options exercised | € (32) (37) (35)  
Total, options cancelled | €     (1) [1]  
Total, ending balance | € € 75 € 107 € 144 € 180
[1] (a)Mainly due to the grantees leaving Sanofi